Please enter both email and password to log in
|
|
You need to upgrade your Flash Player to view this content.
What's New?
CME-certified case study now live!
Our newest CME-certified case study, authored by CCMD Faculty Member Neil J. Stone, MD, focuses on a multifactorial approach to lipid lowering in the high-risk patient. This case offers the latest evidence-based information on the appropriate diagnosis, treatment, and management of patients with established coronary artery disease.
|
CMDManagement™ Fall/Winter 2007 issue now available for CME credit
This issue of our award-winning newsletter explores the latest advances in managing global cardiovascular risk in special populations. Also featured: a case study underscoring the role of primary prevention in the high-risk patient and a patient-education handout offering tips on maintaining arterial health, with a spotlight on peripheral arterial disease.
|
The latest in clinical literature
New selections: The association between physical activity and cardiovascular event risk, featuring expert commentary from CCMD Faculty Member Ezra A. Amsterdam, MD; baseline characteristics of participants in JUPITER; impact of the metabolic syndrome on macro- and microvascular outcomes in type 2 diabetes in UKPDS; and much more.
|
New slides from our recently concluded Virtual Conference series
Download more than 60 slides from our Virtual Conference series, Managing Patients With Atherogenic Dyslipidemia: Beyond LDL-C. The slides, featuring a didactic presentation and a case study, underscore clinical approaches to reducing the cardiovascular risk inherent with atherogenic dyslipidemia.
|
Clinical Insights® in Lipid Management Issue 11 now available
Co-Editor and CCMD Education Council Member John C. LaRosa, MD, comments on the effects of dyslipidemias from childhood to adulthood on CIMT, elasticity, and brachial flow-mediated dilatation. Also featured: the utility of TG/HDL ratio versus TC/HDL ratio for predicting insulin resistance and cardiometabolic risk; and the efficacy and safety of single-pill amlodipine/atorvastatin therapy to attain BP and dyslipidemia goals among African American patients who are at risk for CVD.
|
New drug treatment table for hypertension
Read and download this new table that organizes various pharmacologic treatment options for hypertension, including diuretics, adrenergic inhibitors, alpha- and beta-blockers, direct vasodilators, calcium channel blockers, ACE inhibitors, ARBs, and more.
|
In the News
New CDC Study Finds Arthritis Can Be A Barrier For Adults Seeking To Manage Diabetes Through Physical Activity
May 09, 2008 -- More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity-an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today?s Morbidity and Mortality Weekly Report.Nationwide, 46.4 million adults have arthritis and 20.6 million adults have diabetes, with nearly 7 in 10 having had diabetes diagnosed by a health professional.
|
AOA Champions National Effort To Combat Diabetes
May 09, 2008 -- The American Optometric Association (AOA), representing over 34,000 members in more than 6,500 communities nationwide, joined with other health care provider groups, government officials and leaders from the business and academic communities to announce a new national effort to stem the tide of diabetes in the United States. Unveiled May 7 at the Newseum in Washington, D.C.
|
|
|
|
|
CCMD Co-Chairmen
|
Education Council
George L. Bakris, MD
|
Elizabeth Barrett-Connor, MD
|
Keith C. Ferdinand, MD
|
JoAnne M. Foody, MD
|
Peter Ganz, MD
|
Philip B. Gorelick, MD, MPH
|
Scott M. Grundy, MD, PhD
|
Steven M. Haffner, MD
|
Ronald M. Krauss, MD
|
John C. LaRosa, MD
|
Peter Libby, MD
|
Thomas A. Pearson, MD, MPH, PhD
|
|
|